Hypercalcaemia of malignancy survey

Dear colleagues,

Hypercalcaemia of malignancy is the commonest metabolic complication in cancer patients and there is a lack of evidence in this area, leading to potential variation in clinical practice.

We are interested to know how hypercalcaemia of malignancy is managed in your clinical practice. We would be grateful if you could complete and disseminate this survey.

The survey will take under 5 minutes to complete. The results will be collated and shared anonymously. Your responses are very valuable and will contribute to the ongoing work around management of hypercalcaemia in malignancy.

Thank you for your time and contribution.

https://forms.office.com/Pages/ResponsePage.aspx?id=slTDN7CF9UeyIge0jXdO42vOq5V-X79Lk7YUbqNtpj9URUVBNUdKS0I0M0JNWDZBT0kxOFJFS041Vy4u

BOPA, UKAOS and the Endocrinology Project Team

Latest News

By EDI Subcommittee on 8th November 2024

BOPA EDI membership survey

We invite you to take part in a quick BOPA EDI membership survey. Your responses will assist the BOPA Equity, Diversity and Inclusion (EDI) subcommittee to better serve the membership…

Read article
By BOPA Research Committee on 8th November 2024

Healthcare Professional’s Experiences & Perceptions of Switching Brands of oral SACT – Survey

Dear BOPA members In cancer care, little is known about the impact of specific brands of oral SACT medication or how healthcare professionals respond and process brand switches of oral…

Read article
By BOPA Passport pillar on 6th November 2024

Request for membership to create or review content for BOPA Digital SACT passport (Update)

Dear Member, Regarding the earlier communication for registering to become a creator/reviewer of mock prescriptions: This process has been amended and creation/review is open to free associates and above, as…

Read article
By Netty Cracknell on 6th November 2024

Independent Sector Cancer Network (ISCN) Publish NEW Cancer Service Guidelines

The Independent Sector Cancer Network (ISCN) is a strategic quality governance and safety group which aims to improve independard sector cancer provision though effective collaboration and sharing of best practice across the…

Read article